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Monocyte-derived macrophages 
exhibit distinct and more restricted 
HIV-1 integration site repertoire 
than CD4+ T cells
Yik Lim Kok1,2,*, Valentina Vongrad1,2,*, Mohaned Shilaih1,2,*, Francesca Di Giallonardo3, 
Herbert Kuster1,2, Roger Kouyos1,2, Huldrych F. Günthard1,2 & Karin J. Metzner1,2
The host genetic landscape surrounding integrated HIV-1 has an impact on the fate of the provirus. 
Studies analysing HIV-1 integration sites in macrophages are scarce. We studied HIV-1 integration 
site patterns in monocyte-derived macrophages (MDMs) and activated CD4+ T cells derived from 
seven antiretroviral therapy (ART)-treated HIV-1-infected individuals whose cells were infected ex 
vivo with autologous HIV-1 isolated during the acute phase of infection. A total of 1,484 unique HIV-1 
integration sites were analysed. Their distribution in the human genome and genetic features, and the 
effects of HIV-1 integrase polymorphisms on the nucleotide selection specificity at these sites were 
indistinguishable between the two cell types, and among HIV-1 isolates. However, the repertoires of 
HIV-1-hosting gene clusters overlapped to a higher extent in MDMs than in CD4+ T cells. The frequencies 
of HIV-1 integration events in genes encoding HIV-1-interacting proteins were also different between 
the two cell types. Lastly, HIV-1-hosting genes linked to clonal expansion of latently HIV-1-infected 
CD4+ T cells were over-represented in gene hotspots identified in CD4+ T cells but not in those identified 
in MDMs. Taken together, the repertoire of genes targeted by HIV-1 in MDMs is distinct from and more 
restricted than that of CD4+ T cells.
The human immunodeficiency virus-1 (HIV-1) mainly infects cells that express CD4 and the co-receptor CCR5 
or CXCR4, i.e. CD4+ T cells and macrophages1–6. The phenotypes as a result of an HIV-1 infection in mac-
rophages differ considerably from those of CD4+ T cells. For instance, macrophages are more resistant to HIV-1 
cytopathic effects7,8. Specialized macrophages are widely distributed in various tissues, including anatomical 
sanctuaries. Indeed, HIV-1 has been detected in microglial cells of the central nervous system9–11. The involve-
ment of HIV-1-infected macrophages, especially in the central nervous system, leading to the pathogenesis of 
HIV-1-associated diseases has been shown in various studies (reviewed in12).
Although it is conceivable that the different cellular physiology of macrophages in contrast to that of CD4+ 
T cells may contribute to the observed difference in productivity of the HIV-1 provirus in these two cell types, a 
multitude of studies, both in vivo and in vitro, have shown that the host genetic landscape surrounding the pro-
virus does have an impact on the subsequent fate of the provirus. Earlier integration site studies have established 
the host genetic requirements for HIV-1 integration: (i) HIV-1 favours integration into active transcription units 
in gene-dense regions but disfavours centromeric alphoid repeats and human endogenous retrovirus (HERV) ele-
ments13–15, (ii) Alu repetitive elements are over-represented at HIV-1 integration sites14–17, (iii) HIV-1 provirus is 
flanked by the duplicated weakly conserved palindromic sequence 5′ –GT(A/T)AC–3′13,15,17 and (iv) HIV-1 does 
not have a preference in transcription orientation relative to the gene into which it is integrated14,17.
Studies of HIV-1 integration site patterns in macrophages are scarce. This is partly due to the number of 
HIV-1-infected macrophages that can be recovered from blood samples of HIV-1-infected individuals 
is too low for HIV-1 integration site analysis, and obtaining them from other tissues is too invasive. Hence, 
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ex vivo infection of primary monocyte-derived macrophages (MDMs) is a practical solution. The study of Barr 
et al.18 examined HIV-1 integration site patterns in MDMs and compared them with those in CD4+ T cells 
obtained from other studies. They observed that HIV-1 integration events are found more often in long intergenic 
regions and, correspondingly, less often in gene-dense regions in MDMs compared to CD4+ T cells. In the study 
of Wellensiek et al.19, although they had examined HIV-1 integration site patterns in MDMs and CD4+ T cells, 
they focussed on the differences between adult and neonatal cells of each cell type rather than between cell types. 
To date, a systematic comparison of HIV-1 integration site patterns between MDMs and CD4+ T cells derived 
from the same experimental settings has never been done.
Here, we extended the characterization of HIV-1 integration site patterns in MDMs and CD4+ T cells in 
an experimental setting that mimics the in vivo situation. We used MDMs and CD4+ T cells derived from 
ART-treated HIV-1-infected individuals and infected these cells ex vivo with the individuals’ autologous HIV-1 
isolated during the acute phase of their HIV-1 infection. We focussed on other aspects of HIV-1 integration site 
patterns, e.g. structural and functional gene clusters formed by HIV-1-hosting genes and the frequencies of HIV-1 
integration events in certain gene subsets, and compared these features between the two cell types. We also exam-
ined the effects of two naturally occurring amino acid polymorphisms in the HIV-1 integrase on its nucleotide 
selection specificity at HIV-1 integration sites in primary cells. We showed that the repertoire of genes targeted by 
HIV-1 in MDMs was distinct and more restricted than that of CD4+ T cells.
Results
Characteristics of study participants and their autologous primary HIV-1 isolates. At the time 
of autologous HIV-1 isolation, the study participants were infected with HIV-1 for an estimated 15–153 days 
(Supplementary Table S1). All HIV-1-infected individuals are enrolled in the Zurich Primary HIV Infection 
(ZPHI) study20 and six of seven HIV-1-infected individuals started early ART during the acute phase of infection. 
The replication capacities of these primary HIV-1 isolates in MDMs were most comparable to that of HIV-1JR-FL, 
a macrophage-tropic strain. The replication capacity of primary HIV-1 isolate 6 in MDMs was consistently the 
highest among the seven primary HIV-1 isolates (Supplementary Figure S1). All primary HIV-1 isolates were also 
replication competent in CD4+ T cells (Supplementary Figure S2).
At the time of MDMs and CD4+ T cell isolation from HIV-1-infected individuals, viral suppression ranged 
from 2.8–7.8 years (mean = 4.7 yr) (Supplementary Table S1). These cells were then infected ex vivo with autol-
ogous primary HIV-1 isolates or heterologous HIV-1 isolates. The non-restrictive linear amplification-mediated 
polymerase chain reaction (nrLAM-PCR)21 was used to amplify the 5′ HIV-1 integration junctions, which were 
analysed using our new Integration Site Analysis Pipeline (InStAP) (Supplementary Figure S3). Prior to these 
experiments, CD4+ T cells from three ART-treated HIV-1-infected individuals were activated and monitored 
for HIV-1 outgrowth. Reactivation of HIV-1 from latently infected cells did not occur within 7–8 days (data not 
shown). Thus, we are certain that the HIV-1 integration sites amplified from CD4+ T cells after two days of acti-
vation and a further two days of ex vivo infection were the result of these ex vivo infections. More importantly, no 
HIV-1 integration sites were found in mock infected cell samples of HIV-1-infected individuals.
The basic genetic requirements for HIV-1 integration were similar among individual HIV-1 iso-
lates and between MDMs and CD4+ T cells. We obtained a total of 1,484 unique HIV-1 integration sites, 
derived from the seven selected HIV-1-infected individuals whose MDMs (n = 987) and CD4+ T cells (n = 497) 
were infected ex vivo with autologous primary HIV-1 isolates and heterologous HIV-1 isolates (Supplementary 
Table S2). Of these, 783 (79.3%) and 431 (86.7%) integration sites were found within genes in MDMs and CD4+ 
T cells, respectively. HIV-1 integration sites were also found mainly in gene-dense regions and away from cen-
tromeres, Giemsa dark regions, and the p arms of acrocentric chromosomes in both MDMs and CD4+ T cells 
(Fig. 1). The genic distribution and genetic profiles of HIV-1 integration sites were consistent with previous stud-
ies14,18,22, and they were indistinguishable between MDMs and CD4+ T cells, as well as between pooled autologous 
and heterologous HIV-1 isolates (Supplementary Figure S4). These basic genetic requirements for HIV-1 integra-
tion were also similar among individual HIV-1 isolates (Supplementary Figure S5).
Amino acid residue polymorphisms in HIV-1 integrase altered its nucleotide selection spec-
ificity in primary cells but not the genetic patterns of HIV-1 integration sites. Recent reports 
have identified the amino acid residues in the HIV-1 integrase that dictate the nucleotide selection specificity 
at integration sites, i.e. S119, T122, R231, and K258, in cell lines23,24. Since the full-length genomes of all well 
characterized primary HIV-1 isolates were sequenced, we could analyse these amino acid residues of our seven 
primary HIV-1 isolates and two clonal HIV-1 strains. Six HIV-1 isolates had the most common amino acid res-
idues in all four positions. Primary HIV-1 isolates 2 and 6 exhibited a polymorphism at positions 122 (T122I) 
and 119 (S119P), respectively. These two polymorphisms were present concurrently in primary HIV-1 isolate 5 
(Supplementary Figure S6). We investigated the effects of S119P and T122I polymorphisms on the nucleotide 
selection specificity at HIV-1 integration sites independently by analysing the 20 nucleotide positions immedi-
ately upstream of HIV-1 integration junctions (nucleotide position 0) in both MDMs and CD4+ T cells.
We analysed two nucleotide positions that were previously reported to be altered by the S119P HIV-1 integrase 
variant23. S119P resulted in a significantly increased preference for adenines at positions − 8 (p < 0.0001) and − 9 
(p < 0.01) in both MDMs and CD4+ T cells (Fig. 2a), consistent with previous report23. T122I significantly decreased 
the preference of HIV-1 for thymines at position − 8 in MDMs (p < 0.0001) (Fig. 2b), similar to the previously 
reported T122K23. Nonetheless, a consistent decrease in preference of HIV-1 for thymines at positions − 4 and − 8 was 
observed in both MDMs and CD4+ T cells (Fig. 2b). Primary HIV-1 isolate 5, which exhibited both polymorphisms 
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Figure 1. Chromosomal distribution of HIV-1 integration sites in monocyte-derived macrophages and 
CD4+ T cells infected ex vivo. Inner red lines indicate the position at which HIV-1 was found and outer blue 
peaks indicate gene densities. In each chromosome, red bands indicate centromeres, darker bands are AT-rich, 
and lighter bands are GC-rich.
Figure 2. Conservation and frequency plots of 20 host nucleotides upstream of integrated HIV-1. (a) Left 
panel shows the nucleotide selection specificity of HIV-1 with a serine residue at position 119 of the HIV-1 
integrase protein in a T122 background. Right panel shows the nucleotide selection specificity of HIV-1 with 
serine substituted by a proline residue at position 119 of the HIV-1 integrase protein in a T122 background.  
(b) Left panel shows the nucleotide selection specificity of HIV-1 with a threonine residue at position 122 of the 
HIV-1 integrase protein in an S119 background. Right panel shows the nucleotide selection specificity of HIV-1 
with threonine substituted by an isoleucine residue at position 122 of the HIV-1 integrase protein in an S119 
background. χ 2 test: *p < 0.01 and **p < 0.0001 compared to the same nucleotide positions in the left panel.
www.nature.com/scientificreports/
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in its integrase, could not be analysed due to the lack of sufficient HIV-1 integration sites. Both polymorphisms (S119P 
and T122I) dictated the nucleotide selection specificity at HIV-1 integration sites in primary cells.
The repertoire of HIV-1-hosting genes in MDMs was more restricted and distinct from that 
of CD4+ T cells. Next, we assessed whether the annotated features of HIV-1-hosting genes, e.g. involve-
ment in cellular and molecular processes, were different between the two cell types using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID)25,26. The majority of HIV-1-hosting gene clusters 
over-represented in the human genome had annotations associated with structural motifs and domains of DNA 
and proteins in both cell types (Supplementary Figure S7). However, these gene clusters were more diverse in 
CD4+ T cells, which was also the case in most other categories of gene clusters (data not shown). MDMs had more 
over-represented gene clusters that were associated with protein metabolism, regulation, and transport whereas 
the proportion of over-represented gene clusters associated with a variety of other cellular processes, e.g. regula-
tion of apoptosis, was higher in CD4+ T cells (Supplementary Figure S7). There were also gene clusters that were 
observed exclusively in either cell type, e.g. deubiquitination and regulation of axonogenesis in MDMs whereas T 
cell receptor signalling and cell cycle progression in CD4+ T cells (data not shown), which concordantly reflected 
the cellular and molecular functions of the corresponding cell types.
As the diversity of structural and functional HIV-1-hosting gene clusters appeared to be higher in CD4+ 
T cells, we investigated further the extent to which these gene clusters overlap between cell types in order to 
estimate the relative size of the repertoire of genes accessible to HIV-1 for integration. For this purpose, we ana-
lysed the top 40 gene clusters of each data set, including both over-represented and not over-represented gene 
clusters in the human genome. We scored gene clusters having the same or highly similar annotations between 
data sets, and observed that the gene cluster overlap was the highest (47.5%) between MDM/HIV-1autologous and 
MDM/HIV-1heterologous, and decreased by 7.5–15% between MDMs and CD4+ T cells. As expected, between CD4+ 
T cell/HIV-1autologous and CD4+ T cell/HIV-1heterologous, the extent of overlap was lower (32.5%) (Table 1). This 
apparent trend of gene cluster overlaps was reproducible when we included HIV-1 integration site data sets from 
two other studies: the one other publicly available MDM data set (n = 754)18 and another CD4+ T cell data set 
(n = 534)27 (Table 1). Furthermore, to confirm the quality and comparability among data sets, we used a human 
T-lymphotropic virus-1 (HTLV-1) integration site data set from the study of Meekings et al.28 as a denominator 
control (Table 1). All six HIV-1 integration site data sets overlapped to similarly low extents with that of HTLV-1.
Due to the unequal number of HIV-1 integration sites recovered from each HIV-1-infected individual’s sam-
ple infected ex vivo, the observed results could have been driven mainly by samples of two individuals with 
the highest number of recovered HIV-1 integration sites, i.e. individuals 1 and 6 (Supplementary Table S2). To 
address this issue, we performed two analyses: (i) the proportion of HIV-1 integration sites forming the top 40 
gene clusters were compared with the proportion of HIV-1 integration sites recovered from each HIV-1-infected 
individual’s sample and (ii) gene clusters formed with data from individuals 1 or 6 only, and when removed, were 
Data set 1 Data set 2
Top 40 DAVID 
gene cluster 
overlap (%)
MDM/HIV-1a
MDM/HIV-1h 47.5
CD4+ T cell/HIV-1a 32.5
CD4+ T cell/HIV-1h 37.5
MDM/HIV-1h
CD4+ T cell/HIV-1a 37.5
CD4+ T cell/HIV-1h 40.0
CD4+ T cell/HIV-1a CD4+ T cell/HIV-1h 32.5
MDMs18
MDM/HIV-1a 37.5
MDM/HIV-1h 37.5
CD4+ T cell/HIV-1a 27.5
CD4+ T cell/HIV-1h 22.5
CD4+ T cells27
MDM/HIV-1a 37.5
MDM/HIV-1h 37.5
CD4+ T cell/HIV-1a 32.5
CD4+ T cell/HIV-1h 27.5
 HTLV-128
MDM/HIV-1a 22.5
MDM/HIV-1h 20.0
CD4+ T cell/HIV-1a 17.5
CD4+ T cell/HIV-1h 20.0
MDMs18 25.0
CD4+ T cells27 25.0
Table 1.  DAVID structural and functional gene clusters overlap between data sets. HIV-1- and HTLV-
1-hosting genes were clustered based on their structural and functional annotations using DAVID. The top 
40 clusters from all data sets were compared and clusters having the same or highly similar annotations 
were scored. MDM: Monocyte-derived macrophages; a: autologous; h: heterologous; HTLV-1: Human 
T-lymphotropic virus-1.
www.nature.com/scientificreports/
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compared with the entire corresponding data sets. A high correlation (R2 = 0.9774) was observed between the 
proportion of HIV-1 integration sites forming the top 40 gene clusters and that of HIV-1 integration sites recov-
ered from each HIV-1-infected individual’s sample, indicating that each individual’s sample contributed towards 
the formation of the top 40 gene clusters, and the extent of their contributions were concordant with the pro-
portion of HIV-1 integration sites recovered (Supplementary Figure S8). Additionally, data sets containing only 
HIV-1 integration sites derived from HIV-1-infected individuals 1 or 6 versus data sets without these HIV-1 inte-
gration sites overlapped with the entire corresponding data set to comparable levels (Supplementary Table S3), 
demonstrating our observations were neither HIV-1-infected individual-specific nor skewed by these two indi-
viduals who had the highest number of recovered HIV-1 integration sites.
Using the National Centre for Biotechnology Information (NCBI) database of published protein interactions 
between HIV-1 and its cellular host29, we investigated the frequency of HIV-1 integration events in a subset of 
genes encoding HIV-1-interacting proteins. We hypothesized that this frequency would be different between 
MDMs and CD4+ T cells given the lower HIV-1-hosting gene cluster overlap between them (Table 1). Here, we 
expanded our analysis and included a total of 11 HIV-1 integration site data sets: two MDM data sets (n = 987) 
and two CD4+ T cell data sets (n = 497) derived from this study and one other MDM data set (n = 754) and six 
other CD4+ T cell data sets (n = 7,557) obtained elsewhere14,18,27,30–33 (Table 2). We observed an increase of HIV-1 
integration events in genes encoding HIV-1-interacting proteins in MDMs (1.2×) and a significant increase in 
CD4+ T cells (1.4×, p < 0.001) compared to three sets of 5,000 random genes generated in silico (Fig. 3). As the 
CD4+ T cell data sets were derived from both activated and resting states, we further tested if the difference in 
cellular activation states in CD4+ T cells would have an influence on the frequency of HIV-1 integration into 
genes encoding HIV-1-interacting proteins; no significant difference was observed (data not shown). Though 
quantitatively modest, there was a significant difference (p < 0.05) between MDMs and CD4+ T cells (Fig. 3).
Cell type Virus
Number of 
integration sites 
reported Source
MDMs HIV-1 987 This study
CD4+ T cells HIV-1 497 This study
MDMs HIV-1 754 18
CD4+ T cells HIV-1 457 32
CD4+ T cells HIV-1 2661 33
CD4+ T cells HIV-1 2410 30
PBMCs HIV-1 534 27
SupT1 cells HIV-1 524 14
Jurkat cells HIV-1 971 31
Jurkat cells and 
PBMCs HTLV-1 579 28
Table 2.  Data sets examined in this study.
Figure 3. Frequency of HIV-1 integration events in genes encoding HIV-1-interacting proteins. A total of 
three MDM data sets (two derived from this study; closed circles) and eight CD4+ T cell data sets (two derived 
from this study; closed squares) were compared to three sets of 5,000 random genes generated in silico. Details 
of data sets derived from other studies (open symbols) are found in Table 2. HTLV-1 integration site data set 
served as an independent control. Two-tailed Mann-Whitney U test with 95% confidence interval was used to 
test for statistical significance.
www.nature.com/scientificreports/
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Given the consistent trend of gene cluster overlaps, a rigorous assessment to show the robustness of our anal-
ysis, and a significantly different (p < 0.05) over-representation of HIV-1 integration events in genes encoding 
HIV-1-interacting proteins between MDMs and CD4+ T cells, we demonstrated that the repertoires of genes 
accessible to HIV-1 for integration in MDMs and CD4+ T cells were distinct and that of MDMs’ was more 
restricted.
Genes linked to clonal expansion of latently HIV-1-infected CD4+ T cells were targeted more 
frequently in CD4+ T cells but not monocyte-derived macrophages. Expansion of the viral reser-
voir by means of clonal expansion of latently HIV-1-infected CD4+ T cells harbouring HIV-1 proviruses in genes 
of certain functional nature has recently been suggested27,30,32. These genes are referred to as genes linked to clonal 
expansion of latently HIV-1-infected CD4+ T cells here.
We compiled genes linked to clonal expansion of latently HIV-1-infected CD4+ T cells identified in two stud-
ies27,30 and collapsed them into a total of 196 unique genes. Next, we divided each HIV-1 integration site data 
set into two groups; one containing unique protein-coding genes in which HIV-1 was found ≥ 2 times, i.e. gene 
hotspots (Fig. 4) and the other, only once (Fig. 5a). We included seven HIV-1 integration site data sets for this 
analysis: two derived from this study (data sets of the same cell type combined; n = 1,484) and one other MDM 
data set (n = 754) and four other CD4+ T cell data sets (n = 4,613) obtained elsewhere14,18,31–33 (Table 2),
By comparing the frequencies of HIV-1-hosting genes linked to clonal expansion of latently HIV-1-infected 
CD4+ T cells in gene hotspots and genes with single HIV-1 integration events, we observed a highly significant 
increase of genes linked to clonal expansion of latently HIV-1-infected CD4+ T cells in gene hotspots in CD4+ T 
cells (2.5× , p < 0.001), but not in MDMs (Fig. 5b), showing again that the repertoires of genes accessible to HIV-1 
for integration in the two cell types were distinct.
Gene hotspots identified for HIV-1 integration. We identified a total of 75 (9.5%) and 33 (7.7%) genes 
in which HIV-1 was found ≥ 2 times in MDMs and CD4+ T cells, respectively (Fig. 4). Furthermore, ~70% of 
these genes were identified in ≥ 2 HIV-1-infected individuals. As the probability of getting the same gene ≥ 2 
times in multiple data sets was low34, these genes were considered as hotspots for HIV-1 integration here. Three 
gene hotspots were identified ≥ 4 times in both cell types, i.e. MECP2, KANSL1, and UBE2G1, and they were also 
listed in other studies (Table 3). In most cases, HIV-1 proviruses integrated into the same introns (Table 3), and 
they spanned 36 kb, 139 kb, and 22 kb in MECP2, KANSL1, and UBE2G1, respectively.
Discussion
We compared HIV-1 integration sites patterns between macrophages and CD4+ T cells derived from seven 
ART-treated HIV-1-infected individuals whose cells were infected ex vivo with autologous, as well as heterol-
ogous, primary HIV-1 isolates generated during the acute phase of infection. This unique experimental set-up 
allowed us to replicate the in vivo situation for the examination of HIV-1 integration site patterns arising from the 
two major cellular targets of HIV-1 and potentially among different HIV-1 isolates.
Figure 4. Gene hotspots for HIV-1 integration identified in MDMs and CD4+ T cells. Genes in which 
at least two independent HIV-1 integration events were identified in MDMs (n = 75) and CD4+ T cells 
(n = 33) are shown along with the HIV-1-infected individuals’ samples from which these HIV-1-hosting gene 
hotspots were identified. HIV-1-infected individuals’ samples are colour-coded and strand widths are directly 
proportional to the number of independent integration sites. Underlined in red are gene hotspots that were 
identified at least four times in both cell types.
www.nature.com/scientificreports/
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The various genetic features at HIV-1 integration sites were similar among different HIV-1 isolates, regardless 
of whether the virus was autologous or heterologous. However, given that the gene clusters consistently over-
lapped to a higher extent in MDMs, the repertoire of genes accessible to HIV-1 for integration in MDMs appeared 
to be more restricted than and distinct from that of CD4+ T cells. This distinction between the two cell types was 
again reflected in the different frequencies of HIV-1-hosting genes in two gene subsets: genes encoding HIV-
1-interacting proteins and those linked to clonal expansion of latently HIV-1-infected CD4+ T cells. Firstly, we 
observed an over-representation of HIV-1 integration events in the former gene subset in both MDMs and CD4+ 
T cells, but to different extents. Despite the heterogeneity of the NCBI HIV-1 Human Interaction Database29, its 
representativeness and specificity were demonstrated by the substantially lower frequency of HIV-1-interacting 
genes in random and HTLV-1 data sets. Secondly, HIV-1 integration into genes linked to clonal expansion of 
latently HIV-1-infected CD4+ T cells was over-represented in gene hotspots in CD4+ T cells but not in MDMs.
The gene cluster distribution of our CD4+ T cell data set was consistent with that derived from the study of 
Wagner et al.27, whereas such consistency was somewhat lacking between our MDM data sets with that derived 
from the study of Barr et al.18. Comparison of HIV-1 integration sites between MDMs and CD4+ T cells derived 
from the same experimental settings is important, as evident from the absolute percentages of the top 40 DAVID 
gene cluster overlaps; MDMs from the study of Barr et al.18 and CD4+ T cells from the study of Wagner et al.27 
had the same absolute values when compared to MDMs from this study. Nonetheless, the trend of gene cluster 
Figure 5. Frequency of HIV-1 integration events in genes linked to clonal expansion of latently HIV-
1-infected CD4+ T cells. (a) Each HIV-1 integration site data set was first divided into two groups: one 
comprises genes in which two or more HIV-1 integration events were identified (gene hotspots) and the other 
comprises genes in which only single HIV-1 integration events were identified. The frequency of genes linked 
to clonal expansion of latently HIV-1-infected CD4+ T cells in the two groups of genes for each data set was 
determined and the ratio was computed. (b) Ratio of frequency of genes linked to clonal expansion of latently 
HIV-1-infected CD4+ T cells in gene hotspots to in genes with single HIV-1 integration events. Autologous 
and heterologous HIV-1 data sets were combined here (closed symbols). Details of data sets derived from other 
studies (open symbols) are found in Table 2. Each random control comprised 5,000 random genes generated  
in silico instead of genes linked to clonal expansion of latently HIV-1-infected CD4+ T cells. Two random 
controls were analysed for each data set. Two-tailed Mann-Whitney U test with 95% confidence interval was 
used to test for statistical significance.
Gene Cell type
HIV-1-infected 
individual HIV-1 Intragenic region
Other 
studies
MECP2, chr. X
MDM 6 autologous Intron 1/2* (−)
14, 32, 33
MDM 6 autologous Intron 1/2* (−)
MDM 6 heterologous Intron 1/2* (−)
CD4+ T cell 6 autologous Intron 1/2* (−)
CD4+ T cell 1 autologous Intron 1/2* (−)
KANSL1, chr. 17
MDM 1 heterologous Intron 2/3* (+)
14, 31, 33
MDM 2 heterologous Intron 2/3* (+)
CD4+ T cell 1 autologous Intron 2 (+)
CD4+ T cell 1 autologous Intron 5/6* (+)
UBE2G1, chr. 17
MDM 6 autologous Intron 1 (−)
14, 31–33
MDM 1 heterologous Intron 1 (−)
CD4+ T cell 2 autologous Intron 2 (−)
CD4+ T cell 5 heterologous Intron 1 (+)
Table 3.  Gene hotspots for HIV-1 integration identified in both monocyte-derived macrophages and 
CD4+ T cells. Parentheses in the Intragenic region column indicate transcription orientation of HIV-1 
proviruses relative to the genes into which they were integrated: + indicates same whereas − indicates 
convergent. *Transcript variants.
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overlaps was consistent across all data sets that were derived from the same experimental settings, i.e. gene cluster 
overlaps were the highest between MDM data sets, followed by between MDM and CD4+ T cell data sets, and the 
lowest was observed between CD4+ T cell data sets.
We focussed on gene hotspots that were identified at least four times in both cell types, i.e. MECP2, KANSL1, 
and UBE2G1. The products of these genes are involved in transcriptional and post-translational regulations of 
genes35–37. Interestingly, downregulation of MECP2 has been reported to enhance replication of HIV-1NL4-3 in 
Jurkat cells38. Although it was unclear if these gene hotspots, as well as genes encoding HIV-1-interacting proteins 
were highly accessible prior to or upon HIV-1 infection, it is conceivable that they were transcriptionally active 
enough to allow integration14,15,18,31 and/or located in the vicinity of the nuclear pore, close to the incoming HIV-1 
DNA34. The model of Marini et al.34 describes that specific chromatin organization in the nucleus results in cer-
tain genes being closer to the nuclear pore, thus recurrently targeted by HIV-1 for integration. This model could 
be envisaged to be applicable down to the levels of genes, in which certain intragenic regions might be closer and 
more exposed to the incoming HIV-1 DNA. This would explain why HIV-1 proviruses that were found in the 
three gene hotspots preferred integration into the same introns in most cases.
The effect of T122I polymorphism on HIV-1 nucleotide selection specificity has not been reported previ-
ously. This natural and the second most abundant amino acid polymorphism at position 122 consistently altered 
the nucleotide selection specificity of HIV-1, demonstrating its role in integration site targeting. The effect of 
S119P polymorphism on HIV-1 nucleotide selection at the site of integration in cell lines has been described 
by Demeulemeester et al.23, and our observation in primary cells was consistent with theirs. Certain amino acid 
polymorphisms of the HIV-1 integrase, especially at position 119, have been associated with rapid disease pro-
gression23. However, association of natural integrase variants with disease progression could not be examined 
in our study participants because all of them have been successfully treated. Although these HIV-1 integrase 
polymorphisms altered the nucleotide selection specificity at integration sites, they did not have an effect on 
various genetic features at HIV-1 integration sites23. It is likely that the retargeting of HIV-1 was restricted by the 
repertoire of accessible genes in MDMs and CD4+ T cells.
In summary, we demonstrated in various analyses using our own data sets and of others that the repertoires of 
HIV-1-hosting genes targeted by HIV-1 in MDMs and CD4+ T cells were distinct in terms of their structural and 
functional classes and relative sizes. These cell type-dependent HIV-1 integration site patterns might account for 
the differences in the life cycle of HIV-1 in these cell populations.
Methods
HIV-1-infected study participants and HIV-1 negative donors. HIV-1-infected individuals are 
enrolled in the Zurich Primary HIV Infection (ZPHI) study, which is a non-randomized, observational, open-la-
bel, and single-centre study (www.clinicaltrials.gov; ID: NCT00537966; registered 25th September 2007)20. For the 
current sub-study, the inclusion criteria were: (i) HIV-1-infected individuals had at least 1.5 years of viral suppres-
sion of <20 HIV-1 RNA copies/mL plasma with antiretroviral therapy (ART) at the time of cell sample collection, 
and (ii) their primary HIV-1 isolates were capable of replication in monocyte-derived macrophages (MDMs).
Ethics, consent, and permission. This study was approved by the Ethics Committee of the University 
Hospital Zurich and written informed consent was obtained from all HIV-1-infected individuals and HIV-1 
negative donors. All experiments were performed in accordance with the relevant guidelines and regulations.
Generation and sequencing of primary HIV-1 isolates and clonal HIV-1 strains. The generation of 
primary HIV-1 isolates has been described elsewhere39. Briefly, CD4+ T cells from HIV-1-infected individuals in 
the acute phase of infection were co-cultured with activated donors’ peripheral blood mononuclear cells (PBMCs) 
until the HIV-1 p24 levels of the culture supernatant was >2,000 pg/mL prior to harvesting of the viral superna-
tant. HIV-1 p24 levels were measured with an enzyme-linked immunosorbent assay (ELISA)40. The 50% tissue 
culture infectious dose (TCID50) of the primary HIV-1 isolates was determined by co-culturing quadruplicates 
of 5-fold dilutions of primary HIV-1 isolates and scoring the number of p24-positive wells, and the TCID50 was 
subsequently calculated using the method of Reed and Muench41.
HIV-1JR-FL42 and HIV-1NL4-343 were generated by transfecting HEK 293T cells with pJR-FL and pNL4-
3, respectively, and the viral supernatant was harvested and cleared off of cells with a 0.22 μm filter 48 hours 
post-transfection. pJR-FL42 was obtained from Irvin SY Chen and Yoshio Koyanagi, and pNL4-343 was obtained 
from Malcolm Martin through the NIH AIDS Reagent Programme, Division of AIDS, NIAID, NIH.
We had previously developed a sensitive and robust method to amplify and sequence the full-length genomes 
of primary HIV-1 isolates with minimal artefactual in vitro recombination44. The seven selected primary HIV-1 
isolates were all confirmed to be of subtype B as determined by their pol nucleotide sequences using the REGA 
HIV-1 subtyping tool V345.
Ex vivo HIV-1 infection of monocyte-derived macrophages and CD4+ T cells. Blood samples 
of ART-treated HIV-1-infected individuals were first depleted of CD8+ T cells using RosetteSep Human CD8 
Depletion Cocktail (Stemcell Technologies). CD8− PBMCs were isolated by density gradient centrifugation 
using Lymphoprep (Stemcell Technologies). CD14+ monocytes were positively isolated by magnetic-activated 
cell sorting using CD14 microbeads (Miltenyi Biotec) whereas the remaining CD8−CD14− fraction was treated 
functionally as CD4+ T cells. The median purities of CD14+ monocytes and CD4+ T cells were 95.4% and 98.8%, 
respectively, as measured by flow cytometry. CD14+ cells were induced to differentiate into MDMs in RPMI-
1640 (10% (v/v) fetal bovine serum (FBS), 100 U/mL Penicillin, and 100 μg/mL Streptomycin) supplemented 
with 5% (v/v) human serum (Sigma) and 20 ng/mL macrophage-colony stimulating factor (M-CSF) (Peprotech) 
for eight days. CD4+ T cells were activated in RPMI-1640 (10% (v/v) FBS, 100 U/mL Penicillin, and 100 μg/mL 
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Streptomycin) supplemented with 10 U/mL IL-2 (Roche) and cultured in OKT3-coated flasks for two days. 
MDMs and activated CD4+ T cells were infected ex vivo with primary HIV-1 isolates or clonal strains (HIV-1JR-FL 
or HIV-1NL4-3) at an MOI of 0.74–1.0 for six days and 0.01 for two days, respectively.
In the screening of macrophage-tropic primary HIV-1 isolates, HIV-1 negative donors’ blood samples were 
used and treated essentially the same way to obtain MDMs and CD4+ T cells, except that the isolated CD4+ T 
cells were divided into three fractions, activated individually with 5 U/ml phytohaemagglutinin (PHA), 0.5 U/mL 
PHA, and OKT3, and pooled two days later prior to HIV-1 infection ex vivo.
Amplification and sequencing of 5′ HIV-1 integration junctions. The 5′ HIV-1 integration junc-
tions were amplified with the non-restrictive linear amplification-mediated PCR (nrLAM-PCR)21 from a total of 
0.2–1.0 μg of genomic DNA extracted from cells infected ex vivo with HIV-1 isolates. The procedure was essen-
tially the same as described elsewhere21, except: (i) the 3′ primers used for linear, first exponential, and second 
exponential amplifications were 5′ CCCTGGTGTGTAGTTCTGCC3′ , 5′ CAATCAGGGAAGTAGCCTTGTG3′ , 
and 5′ TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGN0–3 TGTGGTAGACCCACAGATCAAG3′ , 
respectively, (ii) the 5′ primer used for second exponential amplification was 5′ GTCTCGTGGGCTCGGAGATG
TGTATAAGAGACAGN0–3GATCTGAATTCAGTGGCACAG3′ , (iii) the cycling conditions for linear amplifica-
tion were 2× (95 °C for 2 min followed by 50 cycles of 95 °C for 45 s, 57 °C for 45 s, and 72 °C for 8 s) and (iv) The 
cycling conditions for first and second exponential amplifications were 95 °C for 2 min followed by 40 cycles of 
95 °C for 45 s, 57 °C for 45 s, and 72 °C for 8 s, and a final extension at 72 °C for 2 min. The HIV-1 5′ LTR-specific 
primers were designed based on the most conserved regions of the consensus sequence of HIV-1 subtype B in the 
Los Alamos HIV Sequence Database. The N0–3 random nucleotides in the primers used for the second exponen-
tial amplification were introduced to increase nucleotide diversity to enable DNA cluster generation during DNA 
sequencing with the Illumina MiSeq platform.
5′ HIV-1 integration junctions were sequenced with the Illumina MiSeq platform. Illumina sequencing adap-
tors were added to 1 ng of purified PCR products in a PCR using the following primers: 5′ AATGATACGGCGAC
CACCGAGATCTACAC(Index)TCGTCGGCAGCGTC3′ and 5′ CAAGCAGAAGACGGCATACGAGAT(Index)
GTCTCGTGGGCTCGG3′ at 0.5 μM each. The cycling conditions were 72 °C for 3 min, 95 °C for 30 s, 12 cycles 
of 95 °C for 10 s, 55 °C for 30 s, and 72 °C for 30 s, and a final extension at 72 °C for 5 min. A total of 12–14 pM of 
purified PCR products were sequenced with the MiSeq Reagent Kit v2 (300 or 500 cycles) with 8% PhiX.
Post-sequencing processing and mapping to the human genome assembly. Sequencing reads 
were filtered to remove low quality reads. True 5′ HIV-1 integration junctions were identified using an in-house 
bioinformatic pipeline, i.e. Integration Site Analysis Pipeline (InStAP), and satisfied the following criteria: 
(i) presence of both the nrLAM-PCR adaptor and 5′ HIV-1 LTR, (ii) host DNA was within 3 nucleotides from 
the end of 5′ HIV-1 LTR, and (iii) ≥ 85% of the lengths of the reads mapped to the human assembly GRCh37.
p13 with ≥ 98% identity. Contaminants were accounted for and removed from all samples in which they were 
identified except the sample that was sequenced first and/or with the highest number of read count. Manuscript 
on the details of InStAP is in preparation.
HIV-1 integration site data sets derived from this study and obtained elsewhere for comparison are shown in 
Table 2. All HIV-1 integration sites derived from this study are listed in Supplementary Table S4.
Bioinformatic databases. Annotated features of HIV-1-hosting genes were assessed using the Database 
for Annotation, Visualization and Integrated Discovery (DAVID)25,26. DAVID groups genes, which are related by 
their structural and functional annotations, into clusters and calculates an enrichment score to indicate if the gene 
clusters were significantly over-represented in a particular genomic background. Clusters of HIV-1-hosting genes 
that were significantly over-represented in the human genome are defined as having a DAVID enrichment score 
>1.3 with the stringency level in DAVID set to high. By definition, a gene cluster having a DAVID enrichment 
score >1.3 was equivalent to an overall geometric mean <0.05 for all its gene members, and a high stringency 
would consider a gene cluster as biologically significant only when the kappa coefficient, κ ≥ 0.85 for at least three 
genes with at least three related annotations between any two.
The National Centre for Biotechnology Information (NCBI) catalogues and provides access to a database of 
published interactions between HIV-1 proteins and its cellular host29. We used the November 2014 release (the 
latest at time of analysis) of the HIV-1 Human Interaction Database, which documented a total of 3,337 unique 
RefSeq protein-coding genes whose products interact physically, as well as indirectly, with HIV-1. This number 
of genes represented ~16.15% of all unique RefSeq protein-coding genes in the human genome (20,664 as of 15th 
of December 2014).
Statistical analyses. Two-tailed Fisher’s exact test, χ 2 test, and Mann-Whitney U test with a 95% confi-
dence interval were used at where indicated.
Graphical plots. Some of the graphical plots were generated using the following online platforms: Plotly 
(https://plot.ly/), WebLogo46,47, and Circos48.
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